We are thrilled to announce that Qinecsa will be sponsoring the World Drug Safety Congress Europe 2024, marking our third year!
EUROPE’S MOST EXCITING DRUG SAFETY & PV EVENT
The World Drug Safety Congress Europe is where key communities and industries come together to discuss the latest advancements in drug safety. From exploring the use of big data and AI in pharmacovigilance to examining benefit-risk management strategies and patient-centric approaches, drug safety is at the forefront of innovative technologies that are set to significantly impact patients’ lives.
Our team of experts is ready to share firsthand insights into our comprehensive drug safety solutions and how we can support the industry with faster and more effective pharmacovigilance. Visit us to learn how we seamlessly integrate cutting-edge technology with scientific expertise, empowering life science companies to access optimal drug safety solutions through our streamlined processes and proven technologies.
We extend a warm invitation to attend the insightful presentation by our Chief Strategy Officer, Martin Holm-Petersen:
Topic: “Future-proofing pharmacovigilance: governance, data collection and analyses for global success.”
When: 12:05pm, Wednesday 9th October
To schedule a meeting with our team and discover how Qinecsa’s scientific proficiency and innovative technologies significantly enhance drug safety data capture, management, and evaluation with heightened efficiency and accuracy.
For an overview of the event agenda, please visit the official World Drug Safety Congress Europe 2024 event website.
We are thrilled to participate in the World Drug Safety Congress Europe 2024, where global industry leaders will tackle key challenges in drug safety, allowing us to demonstrate how our cutting-edge technology and scientific expertise provide solutions that directly address these challenges and help life science companies achieve optimal drug safety outcomes.
We look forward to seeing you there!
